Ahuja HG, Felix CA, Aplan PD. (1999) The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood, 94, 3258-3261.
Atoyebi W, Kusec R, Fidler C et al. (1997) Glutathione S-transferase gene deletions in myelodysplasia. Lancet, 349, 1450-1451.
Baxter EJ, Kulkarni S, Vizmanos JL et al. (2003) Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. British Journal of Haematology, 120, 251-256.
Bench AJ, Nacheva EP, Hood TL et al. (2000) Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene, 19, 3902-3913.
Boultwood J, Fidler C, Kusec R et al. (1997) Telomere length in myelodysplastic syndromes. American Journal of Hematology, 56, 266-271.
Boultwood J, Fidler C, Strickson AJ et al. (2002) Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood, 99, 4638-4641.
Gibbons RJ, Pellagatti A, Garrick D et al. (2003) Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nature Genetics, 34, 446-449.
Golub TR, Barker GF, Lovett M et al. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307-316.
Harada H, Harada Y, Tanaka H et al. (2003) Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Blood, 101, 673-680.
Hofmann WK, de Vos S, Komor M et al. (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood, 100, 3553-3560.
Horiike S, Yokota S, Nakao M et al. (1997) Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia, 11, 1442-1446.
Le Beau MM, Espinosa R 3rd, Davis EM et al. (1996) Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood, 88, 1930-1935.
Miyazato A, Ueno S, Ohmine K et al. (2001) Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood, 98, 422-427.
Padua RA, Guinn BA, Al-Sabah AI et al. (1998) RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia, 12, 887-892.
Pellagatti A, Esoof N, Watkins F et al. (2004) Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. British Journal of Haematology, 125, 576-583.
Ross TS, Bernard OA, Berger R et al. (1998) Fusion of huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGF-betaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood, 91, 4419-4426.
Rowley JD, Reshmi S, Sobulo O et al. (1997) All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood, 90, 535-541.
Rubin CM, Larson RA, Anastasi J et al. (1990) t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood, 76, 2594-2598.
Quesnel B, Guillerm G, Vereecque R et al. (1998) Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood, 91, 2985-2990.
Schoch C, Kohlmann A, Schnittger S et al. (2002) Acute myeloid leuke-mias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 99, 10008-10013.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.